“Pre-Treatment of the Beta3-Adrenergic Receptor Agonist BRL37344 Reduces in Vivo Myocardial Ischemia Reperfusion Injury by Improving AMPK and SIRT1 Activity and by Suppressing MTOR and p70S6K Signaling Pathways”. 2023. Brazilian Journal of Pharmaceutical Sciences 59 (November): e23002. https://doi.org/10.1590/s2175-97902023e23002.